Mike Ludlow, Market Development Manager, Life Sciences; Element Materials Technology provides an assessment of single use systems for biopharmaceutical production and highlights the need for regulatory alignment.
In our latest EPM Online Insight, Jim Sanford, Life Sciences Sector Strategy Manager, Watson-Marlow Fluid Technology Solutions explores how platform technologies enable the scale up of cell and gene therapy processing.
Keytruda is one of the most significant and popular pharmaceuticals in the world. We at EPM have attempted to answer all of the questions you have have in our latest Pharma Explained.
We hear from Don Riach, UK Operations Director at Biocair, who explores approaches to safe and sustainable delivery and next generation packaging for the life sciences sector.
Joel Eichmann, Co-Founder and Managing Director, Green Elephant Biotech explores how the biopharma industry can ensure it is not part of the sustainability problem while developing therapeutic solutions.
Sandoz have entered into a settlement agreement with the class of direct purchaser plaintiffs in the multidistrict litigation entitled In re Generic Pharmaceuticals Pricing Antitrust Litigation.
On Rare Disease Day 2024, we hear from Chris Moore, President, Veeva Europe who explores how companies are overcoming challenges to develop, launch, and educate on new rare disease medicines faster.